CYM2503
CYM2503 is a putative GalR2-positive allosteric modulator. CYM2503 increases the latency to first electrographic seizure and decreases the total time in seizure. CYM2503 also attenuates electroshock-induced seizures in mice. Galanin receptors type 1 (GalR1) and/or type 2 (GalR2) represent unique pharmacological targets for the research of seizures and epilepsy[1].
Product Specifications
CAS Number
1308833-36-4
UNSPSC
12352005
Target
Neuropeptide Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cym2503.html
Purity
96.01
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C1=CC=C(C=C1N2)NC([C@H](CCCCNC(OC(C)(C)C)=O)NC([C@H](CC3CCCCC3)NC(OCC4C5=CC=CC=C5C6=CC=CC=C64)=O)=O)=O)=CC2=O
Molecular Formula
C45H55N5O7
Molecular Weight
777.95
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Escherichia coli O157:H7 N-acetylneuraminate epimerase (nanM)
Recombinant Escherichia coli O157:H7 N-acetylneuraminate epimerase (nanM)
Recombinant Escherichia coli O157:H7 N-acetylneuraminate epimerase (nanM)
Recombinant Escherichia coli O157:H7 N-acetylneuraminate epimerase (nanM)
Recombinant Escherichia coli O157:H7 N-acetylneuraminate epimerase (nanM)